Skip to content
MedsAcross

Medicine

Propranolol 1 mg/1 mL injection

Propranolol · Intravenous
Available on requestPrescription onlyUS FDAGeneric name

Propranolol 1 mg/1 mL injection is a generic prescription medicine for intravenous use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Protect from freezing and excessive heat. Store at 20° to 25°C (68° to 77°F).

Key facts

Active ingredient (INN)
Propranolol
Brand
Sold under the generic name
Strength
1 mg/1 mL
Dosage form
Injection
Route
Intravenous
Packs
10 vials of 1 mL, 1 vial of 1 mL, 1 mL and 4 more
Manufacturers
Medical Purchasing SolutionsFresenius KabiHealthFirstHenry ScheinHikma PharmaceuticalsProPharma Distribution
Origin register
US FDA, United States
Storage
Protect from freezing and excessive heat. Store at 20° to 25°C (68° to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
C07AA05 Propranolol
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
7 September 2001
Identifiers
RxCUI 856443DailyMed set ID 45b0aaf0-df6c-7db0-e063-6294a90a9135, f14ea537-dd5c-4c78-9037-9a85e9e610ef, e586996d-9035-4ef4-8c8d-06e70a02577f +4NDC 84549-604, 63323-604, 0404-9999 +4Application ANDA075826, ANDA077760

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
10 vial, single-dose in 1 tray / 1 mL in 1 vial, single-dose63323-604-01Fresenius Kabi7 September 2001
10 vial in 1 carton / 1 mL in 1 vial0143-9872-10Hikma Pharmaceuticals31 January 2008
1 vial in 1 bag / 1 mL in 1 vial71872-7096-1Medical Purchasing Solutions30 March 2018
1 vial, single-dose in 1 bag / 1 mL in 1 vial, single-dose71872-7195-1Medical Purchasing Solutions16 January 2020
1 mL in 1 vial, single-dose51662-1700-1HealthFirst7 September 2001
1 vial, single-dose in 1 bag / 1 mL in 1 vial, single-dose0404-9999-01Henry Schein15 July 2024
1 mL in 1 vial, single-dose84549-604-01ProPharma Distribution11 December 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 13 November 1967Drugs@FDA
EU (EMA)AuthorisedEMA medicines data
India (CDSCO)Not yet confirmed against CDSCO approval lists—
AustriaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BelgiumRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
BulgariaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CroatiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CyprusRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
CzechiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
DenmarkRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
EstoniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FinlandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
FranceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GermanyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
GreeceRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
HungaryRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IcelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
IrelandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
ItalyRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LatviaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LiechtensteinRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LithuaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
LuxembourgRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
MaltaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NetherlandsRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
NorwayRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PolandRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
PortugalRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
RomaniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SlovakiaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SloveniaRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SpainRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
SwedenRegisteredEuropean Medicines Agency (central authorisation)Checked 12 November 2026
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Propranolol

Clinical summary

Propranolol is a beta-adrenergic blocker indicated in the management of hypertension, among other approved uses. It is available as tablets, extended-release capsules and oral solution for intravenous use. MedsAcross supplies Propranolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Propranolol

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Propranolol 1 mg/1 mL injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.